ConductScience.org, home

Paper6138063

Midazolam: sleep and performance studies in middle age.

Nicholson AN and 1 other. Br J Clin Pharmacol, 1983. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Midazolam: sleep and performance studies in middle age. Papers, record 6138063. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6138063

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Midazolam: sleep and performance studies in middle age.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2019-05-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nicholson ANA N
2Stone BMB M

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
BenzodiazepinesMajor topic
Psychomotor PerformanceMajor topic
SleepMajor topic
Azepines
Humans
Male
Midazolam
Middle Aged
Sleep Stages
Sleep, REM

Source PubMed

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,076,876Hypnotic efficacy in middle age.J Clin Psychopharmacol1982https://conductscience.org/library/papers/7076876PubMed
26,138,080Pharmacokinetics and bioavailability of midazolam in man.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6138080PubMed
36,138,081Pharmacokinetic and clinical considerations in the choice of a hypnotic.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6138081PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
31,712,421Distinct effects of orexin receptor antagonist and GABAA agonist on sleep and physical/cognitive functions after forced awakening.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31712421PubMed
6,394,264Midazolam. A review of its pharmacological properties and therapeutic use.Drugs1984https://conductscience.org/library/papers/6394264PubMed
6,138,075Midazolam and triazolam in out-patients: a double-blind comparison of hypnotic efficacy.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6138075PubMed
6,138,072Efficacy and safety of midazolam and vesparax in treatment of sleep disorders.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6138072PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6138063

GET https://conductscience.org/api/papers/v1/6138063/authors